169 related articles for article (PubMed ID: 38593176)
1. Expression of Toll-like receptors in oral squamous cell carcinoma.
Rusanen P; Marttila E; Amatya SB; Hagström J; Uittamo J; Reunanen J; Rautemaa-Richardson R; Salo T
PLoS One; 2024; 19(4):e0300437. PubMed ID: 38593176
[TBL] [Abstract][Full Text] [Related]
2. TLR4 Expression in Ex-Lichenoid Lesions-Oral Squamous Cell Carcinomas and Its Surrounding Epithelium: The Role of Tumor Inflammatory Microenvironment.
Visioli F; Nunes JS; Pedicillo MC; Leonardi R; Santoro A; Zannoni GF; Aquino G; Cerrone M; Cantile M; Losito NS; Rodolico V; Campisi G; Colella G; De Stefano IS; Ramunno MA; Pizzulli C; Visconti M; Lo Muzio L; Pannone G
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327577
[TBL] [Abstract][Full Text] [Related]
3. TLR1-10, NF-κB and p53 expression is increased in oral lichenoid disease.
Rusanen P; Marttila E; Uittamo J; Hagström J; Salo T; Rautemaa-Richardson R
PLoS One; 2017; 12(7):e0181361. PubMed ID: 28715461
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of toll-like receptor 4 and nuclear factor-κBp65 in oral squamous cell carcinoma patients.
Yang J; Liu D; Khatri KS; Wang J; Zhang G; Meng C; Guan J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):753-764.e1. PubMed ID: 27727111
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors -4 and -5 in oral and cutaneous squamous cell carcinomas.
Omar AA; Korvala J; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Sorsa T; Hagström J; Salo T
J Oral Pathol Med; 2015 Apr; 44(4):258-65. PubMed ID: 25047824
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of VAP-1 in OSCC suppresses tumor growth and metastasis via NF-κB/IL-8 signaling and reduces neutrophil infiltration.
Xu Q; Chen X; Yu T; Tang Q; Zhou Z; Wang H; Huang W; Huang T; Liang F
J Oral Pathol Med; 2022 Apr; 51(4):332-341. PubMed ID: 35174543
[TBL] [Abstract][Full Text] [Related]
7. miR-195 Inhibits Proliferation and Enhances Apoptosis of OSCC Cells via Targeting TLR4.
Wang J; Song R; Wang C; Zhang S; Zhang Y; Zhu Y; Zhao G
J Healthc Eng; 2022; 2022():2270777. PubMed ID: 35310196
[TBL] [Abstract][Full Text] [Related]
8. Candida albicans induces upregulation of programmed death ligand 1 in oral squamous cell carcinoma.
Wang X; Zhao W; Zhang W; Wu S; Yan Z
J Oral Pathol Med; 2022 May; 51(5):444-453. PubMed ID: 35362187
[TBL] [Abstract][Full Text] [Related]
9. AIM2 promotes irradiation resistance, migration ability and PD-L1 expression through STAT1/NF-κB activation in oral squamous cell carcinoma.
Chiu HW; Lee HL; Lee HH; Lu HW; Lin KY; Lin YF; Lin CH
J Transl Med; 2024 Jan; 22(1):13. PubMed ID: 38166970
[TBL] [Abstract][Full Text] [Related]
10. Candida albicans Enhances the Progression of Oral Squamous Cell Carcinoma
Vadovics M; Ho J; Igaz N; Alföldi R; Rakk D; Veres É; Szücs B; Horváth M; Tóth R; Szücs A; Csibi A; Horváth P; Tiszlavicz L; Vágvölgyi C; Nosanchuk JD; Szekeres A; Kiricsi M; Henley-Smith R; Moyes DL; Thavaraj S; Brown R; Puskás LG; Naglik JR; Gácser A
mBio; 2021 Feb; 13(1):e0314421. PubMed ID: 35089096
[TBL] [Abstract][Full Text] [Related]
11. circ_0001461 promotes oral squamous cell carcinoma progression through miR-145/TLR4/NF-κB axis.
Ai Y; Song J; Wei H; Tang Z; Li X; Lv X; Luo H; Wu S; Zou C
Biochem Biophys Res Commun; 2021 Aug; 566():108-114. PubMed ID: 34119822
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment.
Han S; Xu W; Wang Z; Qi X; Wang Y; Ni Y; Shen H; Hu Q; Han W
Oncotarget; 2016 Jun; 7(25):37773-37789. PubMed ID: 27191981
[TBL] [Abstract][Full Text] [Related]
13. Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis.
Sun Z; Luo Q; Ye D; Chen W; Chen F
Mol Cancer; 2012 May; 11():33. PubMed ID: 22583829
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
15. UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF-κB signaling by increasing IκBα degradation.
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Cell Biol Int; 2022 May; 46(5):806-818. PubMed ID: 35128752
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking induces the activation of RIP2/caspase-12/NF-
Qian Y; Wang W; Chen D; Zhu Y; Wang Y; Wang X
PeerJ; 2022; 10():e14330. PubMed ID: 36353608
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
18. Localization of Fusobacterium nucleatum in oral squamous cell carcinoma and its possible directly interacting protein molecules: A case series.
He X; Ma X; Meng Z; Han Z; Chen W
Histol Histopathol; 2023 Aug; 38(8):929-939. PubMed ID: 36478348
[TBL] [Abstract][Full Text] [Related]
19. miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling.
Ma J; Na S; Wang P; Li J; He S; Liu F
Cancer Biother Radiopharm; 2024 Mar; 39(2):144-152. PubMed ID: 35549438
[No Abstract] [Full Text] [Related]
20. Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study.
Kotrashetti VS; Nayak R; Bhat K; Hosmani J; Somannavar P
Biotech Histochem; 2013 Aug; 88(6):311-22. PubMed ID: 23651260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
